Daewoong acquires Chinese drug firm

Published: 2013-08-06 06:56:00

Updated: 2013-08-06 06:56:00

Daewoong Pharmaceutical Co., one of Korea's leading pharmaceutical companies, said last Thursday that it has signed a deal to take over Liaoning Baifeng, a Chinese drug firm, for 18 billion won.

With the acquisition, Daewoong also plans to build a pharmaceutical factory in Shenyang, a northeas...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK